Key facts
- This page summarizes Peter Greenleaf's Form 4 filing for BIODELIVERY SCIENCES INTERNATIONAL INC.
- 2 reported transactions and 1 derivative row are listed below.
- Accepted by SEC: 10 Aug 2021, 18:17.
Peter Greenleaf - 06 Aug 2021 Form 4 Insider Report for BIODELIVERY SCIENCES INTERNATIONAL INC
- Reporting relationship
- Director
- Issuer ticker
- N/A
- Reported as of
- 06 Aug 2021
- Net transaction value
- $0
- SEC form
- 4
- Accepted by SEC
- 10 Aug 2021, 18:17:36 UTC
- Prior SEC filing
- 14 Jun 2021
- Next SEC filing
- 31 Jan 2022
- Source filing
- View source filing
- Reporting owner signature
- /s/ Peter Greenleaf
Source evidence
Original filing metadata and source links for verification.
5 source fields
Reporting owner
1 detail
Key filing fact
Peter Greenleaf filed Form 4 for BIODELIVERY SCIENCES INTERNATIONAL INC on 10 Aug 2021.
Change
- Previous filing in this sequence was filed on 14 Jun 2021.
- Current net transaction value: $0.
Research use
- This tells you what this filing adds before you inspect full transaction and derivative tables.
- You can trace every row back to the original SEC filing document.
Evidence
Filed on Form 4
View source filing
Ownership activity is grounded in SEC Form 4 disclosures.
Reported non-derivative transactions
Shares, units, or other non-derivative securities reported in this filing.
BDSI
transaction
Common Stock
Options Exercise
- Transaction value
- $0
- Shares
- +35,000
- Change %
- +59%
- Price
- $0.000000
- Shares after
- 94,788
- Date
- 06 Aug 2021
- Ownership
- Direct
Reported derivative securities
Options, warrants, convertible securities, or similar derivative positions disclosed in the filing.
BDSI
transaction
Derivative
Restricted Stock Units
Options Exercise
- Transaction value
- $0
- Shares
- -35,000
- Change %
- -67%
- Price
- $0.000000
- Shares after
- 17,500
- Date
- 06 Aug 2021
- Ownership
- Direct
- Underlying class
- Common Stock
- Underlying amount
- 35,000
- Exercise price
- $0.000000
- Footnotes
- F1
* marks a reported price that did not pass the local price check.
Additional SEC filing notes
Filing notes and footnotes
Explanation of responses 1 footnote
Footnote F1
The shares of common stock were acquired by the Reporting Person as a result of the vesting of Restricted Stock Units ("RSUs") granted to the Reporting Person on August 1, 2018 under the Issuer's 2011 Equity Incentive Plan, as amended. The remaining RSUs under this grant will vest as follows: (i) 17,500 RSUs vest in the first open window following the Company's 2022 Annual Meeting of Stockholders.